Your browser doesn't support javascript.
loading
Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.
Leonardi, Craig; Maari, Catherine; Philipp, Sandra; Goldblum, Orin; Zhang, Lu; Burkhardt, Nicole; Ball, Susan; Mallbris, Lotus; Gonzalez, Pablo; Fernández-Peñas, Pablo; Puig, Luis.
Afiliação
  • Leonardi C; Central Dermatology, St. Louis, Missouri. Electronic address: Craig.Leonardi@centralderm.com.
  • Maari C; Innovaderm Research Inc, Montreal, Quebec, Canada; Medical University of Graz, Graz, Austria.
  • Philipp S; Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Goldblum O; Eli Lilly and Company, Indianapolis, Indiana.
  • Zhang L; Eli Lilly and Company, Indianapolis, Indiana.
  • Burkhardt N; Eli Lilly and Company, Indianapolis, Indiana.
  • Ball S; Eli Lilly and Company, Indianapolis, Indiana.
  • Mallbris L; Eli Lilly and Company, Indianapolis, Indiana.
  • Gonzalez P; Buenos Aires Skin SA, Buenos Aires, Argentina.
  • Fernández-Peñas P; Department of Dermatology, Westmead Hospital Dermatology Service, The University of Sydney, Westmead, Australia.
  • Puig L; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
J Am Acad Dermatol ; 79(5): 824-830.e2, 2018 Nov.
Article em En | MEDLINE | ID: mdl-29803904

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados / Etanercepte Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados / Etanercepte Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article